Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus

Chinese Journal of Cancer Research

Volumn 26, Issue 3, 2014, Pages 341-344

  Kim, Young Ae ^a   Lee, Sol ^a   Jung, Ji Woong ^a   Kwon, Yu Jin ^a   Lee, Gyeong Bok ^a   Shin, Dong Gue ^b   Park, Sang Su ^a   Yun, Jin ^a   Jang, Yong Seog ^a   Cho, Dong Hui ^a  

^a Seoul Medical Center   (South Korea)

^b Seoul Red Cross Hospital   (South Korea)

Author keywords

Acute pancreatitis; Dexamethasone; Hypertriglyceridemia; Tamoxifen; Type 2 diabetes mellitus

Indexed keywords

AMYLASE; DEXAMETHASONE; FENOFIBRATE; GABEXATE; GOSERELIN; HYDROCORTISONE; IMIPENEM; INSULIN; MORPHINE; PACLITAXEL; PETHIDINE; TAMOXIFEN; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC DISCOMFORT; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN INFUSION; LIPID ANALYSIS; MEDICAL HISTORY; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PREMEDICATION; RISK BENEFIT ANALYSIS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84903890511     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2014.05.01     Document Type: Article

References (15)

1. Lin HH, Hsu CH, Chao YC. Tamoxifen-induced severe acute pancreatitis: a case report. Dig Dis Sci 2004;49:997-9. (Pubitemid 39012285)
2. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001;344:1997-2008. (Pubitemid 32568155)
3. Noguchi M, Taniya T, Tajiri K, et al. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen. Br J Surg 1987;74:586-7. (Pubitemid 17102498)
4. Colls BM, George PM. Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use. Clin Oncol (R Coll Radiol) 1998;10:270-1. (Pubitemid 28454551)
5. Elisaf MS, Nakou K, Liamis G, et al. Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. Ann Oncol 2000;11:1067-9.
6. Artac M, Sari R, Altunbas H, et al. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer. J Chemother 2002;14:309-11. (Pubitemid 34734577)
7. Vinklerová I, Procházka M, Procházka V, et al. Incidence, severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci 2010;55:2977-81.
8. Ewald N, Hardt PD, Kloer HU. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol 2009;20:497-504.
9. Lin HH, Hsu CH, Chao YC. Tamoxifen-induced severe acute pancreatitis: a case report. Dig Dis Sci 2004;49:997-9. (Pubitemid 39012285)
10. Alagozlu H, Cindoruk M, Unal S. Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis. Clin Drug Investig 2006;26:297-302. (Pubitemid 43845695)
11. Sakhri J, Ben Salem C, Harbi H, et al. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge. JOP 2010;11:382-4.
12. Bagdade JD, Yee E, Albers J, et al. Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism 1976;25:533-42.
13. Hinds TD Jr, Stechschulte LA, Cash HA, et al. Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ). J Biol Chem 2011;286:42911-22.
14. Gouda HN, Sagoo GS, Harding AH, et al. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010;171:645-55.
15. Bagdade JD, Wolter J, Subbaiah PV, et al. Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition. J Clin Endocrinol Metab 1990;70:1132-5.